These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2533741)
1. [Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease]. Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A; Ahmadi R Vasa Suppl; 1989; 27():244-6. PubMed ID: 2533741 [No Abstract] [Full Text] [Related]
2. Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A Thromb Res; 1988 Nov; 52(3):219-26. PubMed ID: 2973666 [TBL] [Abstract][Full Text] [Related]
3. Influence of acetylsalicylic acid (1.0 g/day) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. Minar E; Ehringer H Thromb Res; 1987 Mar; 45(6):791-802. PubMed ID: 2954264 [TBL] [Abstract][Full Text] [Related]
4. Lack of elevation of beta-thromboglobulin and platelet factor 4 in plasma during exercise in patients with chronic peripheral arterial occlusive disease. Minar E; Ehringer H; Schöfl R Klin Wochenschr; 1987 May; 65(9):419-23. PubMed ID: 2955158 [TBL] [Abstract][Full Text] [Related]
5. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension. Gomi T; Ikeda T; Yuhara M; Sakurai J; Nakayama D; Ikegami F J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397 [TBL] [Abstract][Full Text] [Related]
6. Reproducibility of platelet survival time measurements in patients with peripheral arterial occlusive disease. Minar E; Ehringer H Thromb Res; 1987 Oct; 48(1):73-9. PubMed ID: 2962335 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease. Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468 [TBL] [Abstract][Full Text] [Related]
8. Platelet alpha granule secretion in cerebral ischemia: effect of short and long term low dose aspirin treatment. D'Andrea G; Joseph R; Cananzi AR; Ferro-Milone F; Grunfeld S; Toldo M; Welch MA Funct Neurol; 1988; 3(2):179-85. PubMed ID: 2456969 [TBL] [Abstract][Full Text] [Related]
10. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome. Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902 [TBL] [Abstract][Full Text] [Related]
11. Platelet factor 4 and beta thromboglobulin in Moya-Moya disease. Albala MM; Levine PH Am J Pediatr Hematol Oncol; 1984; 6(1):96-9. PubMed ID: 6201080 [TBL] [Abstract][Full Text] [Related]
12. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy. Kasperska-Zajac A; Brzoza Z; Rogala B Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641 [TBL] [Abstract][Full Text] [Related]
13. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases. Viero P; Cortelazzo S; Bassan R; Barbui T Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841 [TBL] [Abstract][Full Text] [Related]
14. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease. Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389 [No Abstract] [Full Text] [Related]
15. Platelet activation during steady state sickle cell disease. Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV J Med; 1983; 14(1):17-36. PubMed ID: 6224876 [TBL] [Abstract][Full Text] [Related]
16. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. Zahavi J; Zahavi M Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of platelet damage in two different centrifugal pumps based on measurements of alpha-granule packing proteins. Mohara J; Kawahito K; Misawa Y; Fuse K Artif Organs; 1998 May; 22(5):371-4. PubMed ID: 9609343 [TBL] [Abstract][Full Text] [Related]
18. [Platelet function in tension headache]. Leira R; Castillo J; Castro A; Rodríguez JR; Lema M; Noya M Neurologia; 1990 Mar; 5(3):78-81. PubMed ID: 2141791 [TBL] [Abstract][Full Text] [Related]
19. Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks. Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Manzoni S; Tonin P; De Zanche L; Girolami A Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():263-5. PubMed ID: 2408445 [No Abstract] [Full Text] [Related]
20. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin]. Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]